22. [IF=3.4] Ruo-yan Yang et al."Pharmacokinetics, anti-rheumatoid arthritis activity, and active ingredient contents of Eucommia ulmoides Oliv."FITOTERAPIA.10.1016/j.fitote.2023.105667 21. [IF=4.9] Zhang Min et al."Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro."Chinese Medicine.2023 Dec;18(1):1-14 20. [IF=2.586] Chenxi Wang et al."Discovery of metabolic markers for the discrimination of Helwingia species based on bioactivity evaluation, plant metabolomics and network pharmacology."RAPID COMMUNICATIONS IN MASS SPECTROMETRY.2022 Oct;:e9411 19. [IF=4.451] Xue-song Wang et al."The antihypertensive effects of Eucommia ulmoides leaf water/ethanol extracts are chlorogenic acid dependent."Journal of Functional Foods. 2022 Jul;94:105129 18. [IF=3.352] Mi-jun Peng et al."Dietary supplementation Eucommia ulmoides extract at high content served as a feed additive in the hens industry."Poultry Sci. 2021 Dec;:101650 17. [IF=3.503] Yongfeng Zhang et al.Aucubin slows the development of osteoporosis by inhibiting osteoclast differentiation via the nuclear factor erythroid 2-related factor 2-mediated antioxidation pathway.Pharm Biol. 2021;59(1):1556-1565 16. [IF=1.902] Chenxi Wang et al."Multiple component-pharmacokinetic studies on 10 bioactive constituents of Peiyuan Tongnao capsule using parallel reaction monitoring mode."Biomed Chromatogr. 2021 Oct;35(10):e5153 15. [IF=2.629] Guan Mengqi et al."The Aqueous Extract of Eucommia Leaves Promotes Proliferation, Differentiation, and Mineralization of Osteoblast-Like MC3T3-E1 Cells."Evid-Based Compl Alt. 2021;2021:3641317 14. [IF=3.701] Bo Ma et al."Aucubin alleviates diabetic nephropathy by inhibiting NF-κB activation and inducing SIRT1/SIRT3-FOXO3a signaling pathway in high-fat diet/streptozotocin-induced diabetic mice."J Funct Foods. 2020 Jan;64:103702 13. [IF=4.142] Wang Chenxi et al."Systematic quality evaluation of Peiyuan Tongnao capsule by offline two-dimensional liquid chromatography/quadrupole-Orbitrap mass spectrometry and adjusted parallel reaction monitoring of quality markers."Anal Bioanal Chem. 2019 Nov;4 12. [IF=6.529] Qi Huang et al."Systematic investigation of the pharmacological mechanism for renal protection by the leaves of Eucommia ulmoides Oliver using UPLC-Q-TOF/MS combined with network pharmacology analysis."Biomed Pharmacother. 2021 Aug;140:111735 11. 刘锟,王健英,魏莉,潘颖宜,袁颖.HPLC法测定杜仲皮、叶、雄花中8种成分[J].中成药,2021,43(03):686-691. 10. 杜庆鑫,刘攀峰,魏艳秀,庆军,杜红岩.基于主成分与聚类分析的杜仲雄花品质综合评价[J].植物研究,2016,36(06):846-852+859. 9. 杜庆鑫, 魏艳秀, 李钦,等. 杜仲雄花生长发育动态及活性成分量变化[J]. 中草药, 2017, 048(013):2746-2751. 8. 杜庆鑫, 魏艳秀, 刘攀峰,等. 杜仲雄花主要活性成分含量的多样性[J]. 林业科学, 2017, 053(002):35-43. 7. 魏锦锦, 辛东林, 陈翔,等. 蒸汽爆破预处理对杜仲皮活性成分和杜仲胶提取的影响[J]. 林产化学与工业, 2019, 39(1):88-94. 6. 李漓 周小江 袁志鹰 等. 分散固相萃取HPLC测定玄参中五种指标性成分[J]. 海峡药学 2019 031(011):30-33. 5. 何仕如, 李漓, 许光明,等. 固相萃取高效液相色谱法快速测定玄参有效成分[J]. 亚太传统医药, 2020, 016(001):54-57. 4. 刘芳, 黄晓洁, 林美妤,等. 玄参药材等级质量研究[J]. 中药新药与临床药理, 2020年31卷8期, 978-983页, ISTIC PKU CSCD CA, 2020. 3. 周炳文, 钟晓明, 黄真. 玄参环烯醚萜苷热回流提取工艺的优化[J]. 中成药, 2018, 040(006):1292-1297. 2. 兰济艳 刘泽 张芹 裴姿琛 李保会.不同产地杜仲生长特性及叶中主要有效成分含量的差异与动态变化[J].河北农业大学学报 2019 42(01):51-56. 1. 徐多多, 庞欢欢, 江美芳,等. 玄参提取物化学成分及其大鼠血浆移行成分的LC-LTQ-Orbitrap分析[J]. 中国中药杂志, 2016, 41(003):521-527.